In these circumstances, treatment with an OV encoding a set of highly immunogenic, immuno-dominant viral antigens induces populations of anti-viral CD8+ T cells which overwhelm the pre-existing anti-tumor CD8+ T cell populations and which, therefore, significantly inhibit therapy associated with ICI alone. This evidence concerns the gene CD8A and neoplasm.